PURE 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-06-15

• Selling, general and administrative expense was $708,000 and $776,000 for the three months ended April 30, 2026 and 2025, respectively. The decrease of $68,000 was due to reduced board of director fees and personnel costs.

• Other income was $82,000 for the three months ended April 30, 2025. During the three months ended April 30, 2025, we received $82,000 from the U.S. Governments Employee Retention Tax Credit Program.

• Gross margin as a percentage of net product sales, or gross margin percentage, was 58% and 58% for the nine months ended April 30, 2026 and 2025, respectively. Our current year product mix, related to sales, was relatively consistent with the prior year.

• Other income was $8,000 and $79,000 for the nine months ended April 30, 2026 and 2025, respectively. During the nine months ended April 30, 2025, we received $82,000 from the U.S. Governments Employee Retention Tax Credit Program.

• As of April 30, 2026, we had $983,000 in cash and cash equivalents compared with $334,000 in cash and cash equivalents as of July 31, 2025. The net increase in cash and cash equivalents was attributable to cash received from financing activities of $1,973,000, offset by cash used to fund continuing …

相对上期删除的文字 · 来源:10-Q · 2026-03-17

• Selling, general and administrative expense was $847,000 and $871,000 for the three months ended January 31, 2026 and 2025, respectively. The decrease was primarily attributable to decreased board fees, personnel costs and facilities expenses. These decreases were partially offset by increased marke…

• Comparison of the Six Months Ended January 31, 2026 and 2025

• Gross margin as a percentage of net product sales, or gross margin percentage, was 60% and 58% for the six months ended January 31, 2026 and 2025, respectively. The slight increase in gross margin percentage was primarily attributable to the sale of higher margin packaging configurations of our prod…

• As of January 31, 2026, we had $273,000 in cash and cash equivalents compared with $409,000 in cash and cash equivalents as of July 31, 2025. The net decrease in cash and cash equivalents was attributable to cash used to fund operations offset by the note payable financings that occurred during the …

• We have a history of recurring losses, and as of January 31, 2026 we have a stockholder deficiency of $6,273,000. During the six months ended January 31, 2026, we recorded a net loss of $1,249,000 on recorded net revenue of $1,152,000. In addition, during the six months ended January 31, 2026 we use…